Adrenal Insufficiency: Addison's Disease & Adrenal Crisis

An Adrenal Crisis Can Kill Within Hours

Adrenal insufficiency (AI) has a global prevalence of approximately 100–140 cases per million people, making it relatively rare — but its consequences when unrecognized are catastrophic. Without adequate cortisol, the body cannot maintain blood pressure during physiological stress, regulate glucose, or mount an appropriate inflammatory response. An adrenal crisis — acute, severe cortisol deficiency — causes hypotension, altered consciousness, hypoglycemia, and hyponatremia that can progress to circulatory shock and death within hours if untreated. Mortality from adrenal crisis remains 6–7% even in modern medical settings, largely from delayed recognition.

The condition divides cleanly into two mechanistically distinct categories — primary and secondary — with different causes, different hormonal deficits, and different treatment considerations.

Primary vs. Secondary Adrenal Insufficiency

Primary adrenal insufficiency (PAI), classically called Addison's disease, results from destruction or dysfunction of the adrenal cortex itself. The adrenal gland fails to produce both cortisol and aldosterone. In autoimmune Addison's disease — the cause in 70–80% of PAI cases in high-income countries — antibodies against 21-hydroxylase (an enzyme critical for cortisol synthesis) destroy adrenocortical cells. Autoimmune Addison's is often part of autoimmune polyglandular syndrome type 1 or 2, co-occurring with type 1 diabetes, Hashimoto's thyroiditis, or primary ovarian insufficiency.

Secondary adrenal insufficiency (SAI) results from insufficient ACTH from the pituitary, which fails to stimulate the adrenal cortex. The adrenal gland is structurally intact but functionally dormant from lack of stimulation. SAI is far more common than PAI, with prevalence estimated at 150–280 per million — largely driven by the widespread use of exogenous glucocorticoids (prednisone, dexamethasone, inhaled steroids) that suppress the HPA axis through negative feedback. Pituitary adenomas, craniopharyngiomas, and pituitary surgery or radiation account for most non-drug causes.

Diagnosis: The ACTH Stimulation Test

No single basal cortisol measurement is sufficiently reliable to diagnose adrenal insufficiency, except at the extremes. A morning serum cortisol below 3 mcg/dL has high sensitivity for AI; above 18–20 mcg/dL (lab-dependent) essentially excludes it. Values between 3–18 mcg/dL require dynamic testing.

The standard-dose ACTH stimulation test (cosyntropin test, Synacthen test) administers 250 mcg of synthetic ACTH intramuscularly or intravenously, with cortisol measured at 0, 30, and 60 minutes. A peak cortisol above 18–20 mcg/dL (depending on the assay) is considered a normal response, ruling out primary AI and most established secondary AI. The test is less reliable for recently acquired secondary AI (such as following pituitary surgery within 4–6 weeks) because the adrenal cortex has not yet atrophied — making it still capable of responding to exogenous ACTH despite being deprived of endogenous stimulation.

• Low-dose cosyntropin test (1 mcg): potentially more sensitive for mild secondary AI; less standardized across laboratories
• Insulin tolerance test (ITT): gold standard for hypothalamic-pituitary axis assessment; dangerous in patients with seizure disorders, CAD; requires intensive monitoring
• CRH stimulation test: helps distinguish hypothalamic from pituitary causes of secondary AI

Cortisol Replacement: Dosing and Principles

The goal of cortisol replacement is physiological mimicry of the normal diurnal pattern, not chronic high-dose suppression. The typical adult replacement dose of hydrocortisone (the preferred glucocorticoid for AI because its 8-hour half-life allows rhythm approximation) is 15–25 mg/day in divided doses — typically two-thirds in the morning and one-third in early afternoon, mimicking the natural cortisol peak and decline.

Older regimens used 30–40 mg/day, which research has shown was supraphysiological. The 2014 Endocrine Society guidelines and 2020 European Adrenal Insufficiency Consortium (EU-AIR) data confirmed that higher replacement doses are associated with increased cardiovascular mortality, obesity, and osteoporosis. Modern practice targets the lowest effective dose.

Primary AI also requires mineralocorticoid replacement. Fludrocortisone 50–200 mcg/day replaces aldosterone's sodium-retaining, potassium-excreting function — failure to replace mineralocorticoids causes salt-wasting, volume depletion, hyperkalemia, and cardiovascular instability.

Adrenal Crisis Triggers and Sick Day Rules

Approximately 6–8 adrenal crises per 100 patient-years occur in AI patients receiving replacement therapy. Physiological stress — infection, surgery, vomiting — dramatically increases cortisol demand beyond the fixed replacement dose. The "sick day rules" (also called stress dosing) are lifesaving protocols that every AI patient must know:

• Mild illness/fever: double the daily hydrocortisone dose
• Moderate illness/high fever: triple the daily dose
• Vomiting or inability to take oral medications: administer emergency intramuscular hydrocortisone 100 mg and seek emergency care immediately
• Major surgery: perioperative hydrocortisone 50–100 mg IV before incision, with continued stress doses for 24–48 hours

Adrenal Fatigue: A Distinct Concept Without Diagnostic Validity

"Adrenal fatigue," popularized in naturopathic and functional medicine contexts, proposes that chronic stress causes a partial, subclinical decline in adrenal function producing fatigue, brain fog, and sleep disruption without meeting criteria for Addison's disease or secondary AI. The Endocrine Society's 2016 scientific statement explicitly stated that "adrenal fatigue" is not a recognized diagnosis and that the evidence for its existence as a distinct entity is absent. A 2016 systematic review in BMC Medicine analyzed 58 studies and found no consistent evidence that chronic stress produces measurable decrements in adrenal cortisol output in the absence of diagnosable HPA pathology. The symptoms attributed to adrenal fatigue are real — fatigue, mood dysregulation, disrupted sleep are genuine complaints — but their etiology in affected patients most likely lies in sleep disorders, depression, thyroid dysfunction, anemia, or dysautonomia rather than adrenal gland failure.

This article is for informational purposes only. Consult a qualified healthcare professional.